US 11331332
Treatment of increased lipid levels with sterol regulatory element binding protein cleavage-activating protein (SCAP) inhibitors
granted A61KA61K31/7105
Quick answer
US patent 11331332 (Treatment of increased lipid levels with sterol regulatory element binding protein cleavage-activating protein (SCAP) inhibitors) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/7105